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Abstract Schisandra chinensis (Chinese magnolia
vine) is the best-known representative of the genus
Schisandra, widely used in the official East-Asian,
North American and European medicine. The article
recalls the healing value of this species and, above
all, presents the current state of knowledge on the
chemical composition and biological activity of three
other species of the Schisandra genus: Schisandra
sphenanthera, Schisandra henryi and Schisandra
rubriflora. In addition to dibenzocyclooctadiene lig-
nans (the so-called ‘Schisandra chinensis lignans’),
they also contain other groups of lignans (e.g. 4-
aryltetralin, aryltetralone, tetrahydrofuran and
butane-type lignans) as the main compounds respon-
sible for biological activity. The lignans are
accompanied by other groups of compounds, includ-
ing triterpenoids and nortriterpenoids. A review of
biological studies, e.g. of empirically confirmed
hepatoprotective, cytotoxic and anti-HIV-1 activities,
proves that these species have a high therapeutic
potential and may constitute a new East-Asian
proposition for European medicine. The article also
draws attention to the possibility of using the
biosynthetic potential of the biomass from in vitro
cultures of the described species and biotechnological
solutions as an alternative to plant raw materials.
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Introduction
The genus Schisandra includes from 20 to 30 species
(Hancke et al. 1999; Saunders 2000). The natural
habitats of Schisandra species are located in East and
South-East Asia, twelve of those species are endemic
to China (Saunders 2000; Wu et al. 2008). The species
of Schisandra differ from one another in small details
in their morphological structure. The knowledge of the
chemical composition of different parts of these
species (leaves, stems, flowers, or fruits) is not
satisfactory. Most of them are rooted in Traditional
Chinese Medicine (TCM) as medicinal plants (Saun-
ders 2000; Wu et al. 2008; Szopa et al. 2017a).
The best-known worldwide species from this genus
is Schisandra chinensis Turcz. Baill.—Chinese mag-
nolia vine. The knowledge of the valuable medicinal
properties of Schisandra fruits (Bei-wuweizi, Northern
magnolia vine fruit) is based on the Traditional
Chinese Medicine (Fil’kin 1952; Bensky and Gamble
1993). Nowadays, monographs on Schisandra chinen-
sis fruits are included in numerous pharmacopoeias,
not only in Asian countries (China, Japan, South Korea
and Russia) (Korea Food and Drug Administration
2002; Chinese Pharmacopoeia Commission 2005;
Panossian and Wikman 2008), but also in countries
of Europe (European Directorate for the Quality of
Medicines 2017) and USA (Upton et al. 2011). Since
2007, they have also been accepted by International
Pharmacopoeia edited by WHO (World Health Orga-
nization 2007) as medicinal plant raw material. Also,
since 2010, the S. chinensis fruit has been accepted by
the European Food Safety Authority (EFSA) as ‘safe
nutrition ingredients with tonic for the support of
mental and well-being application’ (European Food
Safety Authority 2010). Moreover, S. chinensis is also
recognized as a plausible anti-aging and skin condi-
tioning cosmetics component in the database of the
European Inventory of Cosmetic Ingredients (CosIng)
(Szopa et al. 2016a).
Recently, we documented the state of the art about
the progression of studies on S. chinensis in our
review article (Szopa et al. 2017a). They deal with
bioactive components, pharmacological properties,
analytical and biotechnological researches.
Schisandra chinensis fruit extracts are used in
medicine because of their valuable biological prop-
erties: hepatoprotective, adaptogenic and ergogenic,
anti-cancer, anti-inflammatory, antiulcer, antioxida-
tive and detoxifying (Szopa et al. 2017a). These
activities are mainly driven by dibenzocyclooctadi-
ene lignans, which are called, even in the professional
scientific literature, ‘Schisandra chinensis lignans’
due to their complex, and at the same time unique,
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structure (they are present mainly in the fruit, from
7.2 to 19.2% DW) (Opletal et al. 2004; World Health
Organization 2007; Szopa et al. 2017a) (Table 1).
The main source of this raw material in Europe and
America are imports from Southeast Asia, primarily
from China. The theoretically possible chemical
synthesis of Schisandra lignans involves many stages
and is very complicated. So far, only one synthetic
drug is available—Bifendate (BDD, biphenyl
dimethyl-dicarboxylate), manufactured in China, it
is used in medicine as a hepatoprotective agent
(Shuwei and Haodong 2000).
The majority of scientific work on other species of
the genus Schisandra has been performed in China.
Analysis of the reports shows that potential biological
activities of other species from that genus are very
probable.
The second in the order of S. chinensis species
described in the literature as competing in terms of
medical applications is S. sphenanthera Rehder & E.
H. Wilson (Nan-wuweizi, Southern magnolia vine
fruit) (Huyke et al. 2007; Zhu et al. 2007; Lu and
Chen 2009). However, the chemical compositions of
the fruits of the two Schisandra species (Northern and
Southern magnolia vines) are quite different (Lu and
Chen 2009). Since 2005, the fruits of these two plants
have been recognized as two different raw materials,
namely “bei wuweizi” (Fructus Schisandrae chinen-
sis) and “nan wuweizi” (Fructus Schisandrae
sphenantherae), respectively, by the Chinese Phar-
macopoeia (Chinese Pharmacopoeia Commission
2005; Sun et al. 2010; Wei et al. 2010). On the other
hand, the monograph on Schisandrae chinensis fruit
has appeared in the European Pharmacopoeia since
2008 (European Directorate for the Quality of
Medicines 2013). What is important is the fact that
S. chinensis only was approved as a herbal remedy in
Europe and North America (World Health Organiza-
tion 2007; Upton et al. 2011; European Directorate
for the Quality of Medicines 2017). In its mono-
graphs, one can only find descriptions of
morphological and chromatographic methods of
distinguishing S. chinensis fruit against adulteration
of the raw material with Schisandrae sphenantherae
fructus.
Scientific research on the species of the genus
Schisandra is prominent. Some studies have reported
a high chemical and biological potential of S. henryi
C.B. Clarke (翼梗五味子; yi geng wuweizi) and
S. rubriflora (Franch.) Rehd. et Wils (红花五味子;
hong hua wuweizi) (Wu et al. 2008). These species,
along with S. sphenanthera, could be regarded as
sources of valuable medicinal rawmaterials in Europe.
The major purpose of this review article is to
gain the basic and new knowledge of chemical
composition, biological activities and potential
biotechnological solutions for providing industry
with raw materials.
Importantly, the available databases contain only
one review publication comparing the chemical
composition of S. sphenanthera and S. chinensis
(Lu and Chen 2009). Furthermore, there are no
publications describing the current state of knowl-
edge on the species S. henryi and S. rubriflora.
Natural habitats and possibility of cultivation in
Europe
All species of Schisandra are scandent, i.e. climbing,
woody vines; they lack tendrils or other specialized
structures for climbing, but become entangled on
supporting vegetation by spiral stem growth. All of
the species have a very similar growth pattern, but
Table 1 The predominant dibenzocyclooctadiene lignans detected in the fruits of: S. chinensis, S. sphenanthera, S. henryi and S.
rubriflora
Species Dibenzocyclooctadiene lignans
S. chinensis Schisandrin, schisandrins B and C, gomisins A and G, schisantherins A and B, deoxyschisandrin, γ-schisandrin,
schisanthenol
S. sphenanthera Gomisins: C, S, K3 and J, epigomisin O, 6-O-benzoylgomisin, benzoylgomisin U, methylgomisin,
tigloylgomisin P, angeloylgomisin P, schisantherins A–D, deoxyschisandrin, schisanhenol
S. henryi Schisantherins A and B, deoxyschisandrin, schisandrin, gomisin G, benzoylgomisin Q, isoanwulignan
S. rubriflora Gomisins B, C, G, J, N, O, Q, S and T, isogomisin O, schisandrin, schisandrin A, angeloylgomisins P and Q,
benzoylgomisin Q
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small differences in the morphology of individual
species are visible. The exact morphological and
botanical differences of each Schisandra species were
described by Saunders (2000).
All Schisandras occur naturally in East Asia, from
Hokkaido (Japan) and Far Eastern Siberia in the
north-east, to Java and Bali in the south, and to Uttar
Pradesh (India) in the west. The centre of diversity
lies in south-eastern and south-central China. How-
ever, there are considerable differences between the
spread of individual species. Moreover, one species
—Schisandra glabra, has natural habitats in North
America (Panero and Aranda 1998; Denk and Oh
2005).
Schisandra sphenanthera is a species endemic to
China; it occurs naturally in central and southern
provinces of China: Anhui, Gansu, Guizhou, Henan,
Hubei, Hunan, Jiangsu, Shaanxi, Shanxi, Sichuan,
Yunnan, and Zhejiang. This plant has the growth
habit of a woody vine, apparently dioecious (but
probably monoecious). Leaf laminas are 5.5–11 cm
long and 2.5–6 cm wide, elliptic to ovate. The flowers
borne in axils of fugacious bracts at the base of young
shoots are solitary with variably yellow, orange, or
red tepals (6–8 male flowers, and 5–8 female
flowers). The male flowers have an androecium
composed of 15–23 essentially free stamens. The
gynoecium of female flowers has 25–45 free carpels.
Fruit peduncles are glabrous, 3–6.5 cm long. The
fruits are red, 5–9 mm long and 4–8 mm wide, with
1–2 discoid to flattened-reniform seeds (Saunders
2000; Lu and Chen 2009).
Schisandra henryi has its natural habitat in China
in the province of Yunnan, especially in the southeast
mountains. It is a woody vine, apparently dioecious
(but probably monoecious). Lateral branches are
narrow, with variably persistent perules at the base.
The leaf laminas are 7.5–11.5 cm long and 4.5–
7.5 cm wide, with an elliptic to ovate shape. Flowers
borne in axils of (semi-)persistent perules at the base
of young shoots or in axils of leaves are solitary, with
yellow or orange tepals (6–10 male flowers and 6–8
female flowers). Male flowers have an androecium
with 12–46 essentially free stamens, and the female
flowers have a gynoecium with 28–65 free carpels.
Fruit peduncles are glabrous, elongated (6–10 cm).
The fruits are red, 4.5–8.5 mm long and 3.5–6.5 mm
wide, with 1–2 seeds (discoid to flattened-reniform,
rarely flattened-pyriform) (Saunders 2000).
Schisandra rubriflora occurs naturally only in the
western Sichuan province of China. Its growth habit
is that of a woody vine, apparently dioecious (but
probably monoecious). Lateral branches are lacking
wings, and have fugacious perules at the base. The
leaf laminas are 7–11.5 cm long and 2.5–5.5 cm
wide, glabrous, elliptic to obovate-elliptic. The
flowers are solitary and borne in axils of fugacious
bracts at the base of young shoots. The tepals are
deep (purple-)red and glabrous (6–9 male flowers,
and 6–7 female flowers). The male flowers have an
androecium of 34–66 essentially free stamens spirally
arranged around the floral axis, while the female
flowers have a gynoecium of 50–70 free carpels. The
fruit peduncles are glabrous, elongated, from 5 to
7 cm long, The fruits are dark (purple-)red, 5–8 mm
long and 4–7 mm wide. The seeds are discoid to
flattened-reniform, 1–2 per apocarp (Saunders 2000).
Cropping of Schisandra species outside of the East
Asian area is difficult but possible. There are reports
of successes in cultivation in moderate climates in
Europe and America. The main problem with the
cultivation of the species is related to the low frost
resistance of these plants. However, adequate winter
protection can ensure good growth of the climbing
plants. In addition, there are too few horticultural
reports on the optimal conditions for growing
Schisandra outside of the natural habitats. This is
mainly due to the low popularity of these species, as
they are known only as ornamental plants, planted in
gardens and parks. In Poland, the only distributor of
the species S. rubriflora and S. henryi is the private
nursery ‘Clematis’ (http://www.clematis.com.pl/).
Schisandra lignans—classification, biosynthetic
and chemical characterization
Classification of lignans in the plant kingdom
The Schisandra fruits are characterized by a rich, still
not fully known, chemical composition. The most
important constituents are lignans (Umezawa 2003;
Opletal et al. 2004). There are different classifications
of these compounds. Lignans are classified based on
the way in which oxygen is incorporated into the
skeleton and the cyclization pattern into eight
subgroups: furofuran, furan, dibenzylbutane, diben-
zylbutyrolactone, aryltetralin, arylnaphthalene,
112 Phytochem Rev (2019) 18:109–128
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dibenzocyclooctadiene and dibenzylbutyrolactol
(Whiting 1985, 1990). Another, often assumed classi-
fication, based on chemical structures, divided lignans
into five classes: dibenzocyclooctadiene lignans (type
A), spirobenzofuranoid dibenzocyclooctadiene lignans
(type B), 4-aryltetralin lignans (type C), 2,3-dimethyl-
1,4-diarylbutane lignans (type D), and 2,5-diarylte-
trahydrofuran lignans (type E) (Lu and Chen 2009).
Lignans are plant secondary metabolites of not
fully known biosynthetic pathways (Gottlieb 1972;
Umezawa 2003). The most-accepted biosynthetic
pathway is considered to be the one that leads from
the conversion: coniferyl alcohol→pinoresinol (furo-
furan)→ lariciresinol (furan)→secoisolariciresinol
(dibenzylbutane)→matairesinol (dibenzylbutyrolac-
tone) (Umezawa 2003). But lignans without 9(9′)-
oxygen, like dibenzocyclooctadiene, dibenzylbutane
and furan lignans without oxygen at C9 and C9′, may
be formed by a coupling of propenylphenols such as
isoeugenol (Gottlieb 1972).
Schisandra lignans
The most common, for the genus Schisandra,
subgroup of lignans is that of dibenzocyclooctadiene
lignans, and for this reason they are often, even in
scientific elaborations, called ‘Schisandra lignans’, or
‘Schisandrae chinensis lignans’. The first Schisandra
lignan was isolated by Kochetkov et al. (1961).
Currently, approximately 150 lignan derivatives with
the dibenzocyclooctadiene skeleton have been iso-
lated from plants of the Schisandraceae family (Ren
et al. 2010). Moreover, the naturally occurring
lignans have been found to exist exclusively as one
enantiomer or as enantiomeric mixtures with various
enantiomeric compositions. These compounds can be
further categorized, based on their stereostructures,
into S- or R-biphenyl configuration groups. Structural
elucidation is possible by the use of spectroscopic
techniques, including ultraviolet (UV), infrared (IR),
mass (MS), nuclear magnetic resonance (NMR), and
circular dichroism (CD) spectra, as well as advanced
2D NMR (Opletal et al. 2004).
The dibenzocyclooctadiene-type lignans are very
characteristic for S. chinensis, in which they are the
main component of fruit extracts (World Health
Organization 2007). The main compounds of this
group are: schisandrin, schisandrin C, gomisin A and
G, schisantherin A and B, deoxyschisandrin, γ-
schisandrin and schisanthenol (Table 1). The remain-
ing species are characterized by the presence of still
other subgroups/types of lignans. This fact is a
challenge in many phytochemical studies whose aim
is to obtain the best knowledge of the qualitative and
quantitative composition of other Schisandra species.
This is an important issue in order to provide a useful
reference for good quality control of Schisandra
fruits. The analyses use the most modern spectropho-
tometric and chromatographic methods, including
thin-layer chromatography (TLC), high-performance
liquid chromatography (HPLC), liquid chromatogra-
phy-mass spectrometry (LC–MS and LC–ESI–MS),
capillary electrophoresis (CE) and capillary elec-
trochromatography (CEC) (Chang et al. 2005; Shi
et al. 2009).
Biological activities
Biological activity of lignans is a frequent object of
work in the field of pharmacological studies on the
Schisandra genus (Table 2). The most studied group
of lignans is that of dibenzocyclooctadiene lignans.
Their biological activity is very valuable and deter-
mined individually for separate compounds.
Scientific research has confirmed the hepatopro-
tective and detoxifying properties of lignans for the
liver parenchyma, and also their valuable antioxidant
properties. Dibenzocyclooctadiene lignans also show
immunostimulatory and adaptogenic effects, as well
as antiviral and antibacterial effects. As demonstrated
by studies, dibenzocyclooctadiene lignans also have
protective effects on the myocardium and properties
stimulating the uterine muscle. Moreover, previous
studies have confirmed their beneficial effects on the
central nervous system by protecting nerve cells from
dying and increasing the concentration of neurotrans-
mitters (Hernandez et al. 1988; Lu and Liu 1991;
Yasukawa et al. 1992; Hancke et al. 1994; Ko et al.
1995; World Health Organization 2007; Hwang et al.
2009, 2011; Miao et al. 2009; Xiao et al. 2010c; Chiu
et al. 2011; Waiwut et al. 2012; Chen et al. 2012;
Casarin et al. 2014; Hu et al. 2014; Wang et al. 2015;
Thandavarayan et al. 2015; Szopa et al.
2016a, 2017a). Detailed directions of the biological
activity of dibenzocyclooctadiene lignans are pre-
sented in Table 2.
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Table 2 Bioactivity of dibenzocyclooctadiene lignans supported by scientific studies
Action profile Active ingredient
showing biological
activity
Mechanism of action References
Hepatoprotective
effect
Gomisin A Stimulation of glutathione reductase activity and
reduction of too high levels of ALAT and ASPAT
Increase in the activity of cytochrome B5, P450,
NADPH, cytochrome C reductase, aminophenazone N-
demethylase and O-deetylase-7-ethoxycoumarin
Reduction in the activity of 3-4-dibenzopyrene
hydroxylase
Acceleration of hepatocyte proliferation
Ko et al. (1995)
γ-schisandrin Increase in the concentration of mitochondrial
glutathione
Increase in vitamin C in the liver
Reduction in the affinity of aflatoxins to DNA
Lu and Liu (1991) and Ko
et al. (1995)
Ergogenic and
adaptogenic
effects
Dibenzocyclooctadiene
lignans in general
Reduction in tiredness
Improvement in bodily function, increase in physical
and mental endurance
Improvement in visual acuity at dusk
Hancke et al. (1994) and
Chen et al. (2012)
Anti-
inflammatory
effect
Gomisin A, gomisin J,
schisandrin C
Reduction of inflammation by inhibiting the expression
of nitric oxide and production of prostaglandins
Induction of cyclooxygenase 2 release
World Health Organization
(2007) and Hu et al.
(2014)
Antiulcer activity Dibenzocyclooctadiene
lignans in general
Reduction in peptic ulcer symptoms after consumption
of ethanolic extracts from S. chinensis fruit
Accelerated regeneration of ulcer wounds
Hernandez et al. (1988) and
World Health
Organization (2007)
Antioxidant and
detoxification
effects
Schisandrin, schisandrin
B and C
Inhibition of microsomal lipid peroxidation
Reduction in the amount of superoxide free radicals in
neutrophils
Reduction in the release of ALAT and lactate
dehydrogenase, which increases the viability of
hepatocytes
Increase in hepatic glutathione
Miao et al. (2009), Chiu
et al. (2011) and
Thandavarayan et al.
(2015)
Anti-tumour
effect
Gomisin A and N,
γ-schisandrin
Inhibition of tumour marker production in hepatocytes
(glutathione S-transferase, GST-P)
Reduction in tumour lesions in the liver
Inhibition of the development of skin tumours and the
Papilloma virus
Prevention of cell apoptosis through the production of
heat shock proteins—Hps70
Induction of tumour cell apoptosis
Hwang et al. (2009, 2011),
Waiwut et al. (2012) and
Casarin et al. (2014)
Antiviral activity Gomisin A and N, γ-
schisandrin,
schisanhenol
derivatives
Inhibition of the multiplication of the HIV virus
Inhibition of the multiplication of the Papilloma virus
Inhibition of the multiplication of the tobacco mosaic
virus
Yasukawa et al. (1992),
Xiao et al. (2010c) and
Wang et al. (2015)
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Schisandra triterpenoids
Classification, biosynthetic and chemical
characterization
The second specific group of Schisandra secondary
metabolites are Schisandra triterpenoids. Recently,
numerous studies on this genus have concentrated on
just this group of compounds. Generally, the triter-
penoids from the Schisandraceae family can be
classified into three groups, also according to their
different carbon frameworks: lanostane (A), cycloar-
tane (B), and Schisandra nortriterpenoids (C) (Xiao
et al. 2008a). Schisandra nortriterpenoids is a unique
group of metabolites because of their chemical
structure, which is rarely found in the plant kingdom,
namely being highly oxygenated with different
lactone skeletons. Moreover, the Schisandra nor-
triterpenoids may be further grouped into different
classes including the schisanartane, schiartane,
18-norschiartane, 18(13/14)-abeo-schiartane, pre-
schisanartane and wuweiziartane types (Xiao et al.
2010a). A comprehensive review concentrated on
Schisandra triterpenoids was published in Xiao et al.
(2008a). The researchers also proposed a likely
biosynthetic pathway of this group of secondary
metabolites. A possible biosynthetic pathway could
start from compounds of the cycloartane skeleton—
schizandronic acid, from which ring expansion, 3,4-
oxidative cleavage, oxidation and decarboxylation at
C-28 and epoxidation finally lead to the formation of
a typical schiartane skeleton—micrandilactone B.
Next, the authors suppose that micrandilactone B is a
precursor of various biosynthetic pathways for the
separate types of Schisandra nortriterpenoids (Huang
et al. 2008; Xiao et al. 2008a).
Their work has resulted in the identification of
over 100 bioactive nortriterpenoids (Peng et al.
2015). Extensive investigations of this group of
Schisandra metabolites have been conducted, espe-
cially by Sun and co-workers (Xiao et al.
2006b, 2007c, 2008b; Xue et al. 2010; Shi et al.
2011; Zhou et al. 2011).
Biological properties
Based on the latest studies, this group is growing as a
result of finding and identifying new Schisandra
triterpenoids. Their structure is very unusual and thus
potentially biosynthetically unique, and they may
therefore exhibit potentially significant bioactivities.
Additionally, a large number of these compounds
possess lactone structures, famous in the plant
kingdom as compounds with significant biological
activity. That is the reason why chemical studies are
often coupled with biological ones (Connolly and Hill
2010).
In recent years, considerable efforts of researchers
have been devoted to the discovery of anti-HIV-
bioactivity of triterpenoids from the genus Schisan-
dra (Xiao et al. 2007c). The anti-HIV activity was
shown for sphenalactones A–D (Xiao et al. 2007b)
and sphenadilactone C (Li et al. 2008).
Schinalactones B and C show significant cytotox-
icity activity against PANC-1 cell lines (He et al.
2010), and sphenalactones A–D show low cytotox-
icity activity against C8166 cells (Xiao et al. 2007c).
Specific chemical composition
Schisandra sphenanthera
Schisandra sphenanthera is the second popular
species of the Schisandra genus, after S. chinensis.
This is the reason for the largest number of scientific
studies on the composition and biological activity of
this species. Chemical analyses are conducted on
different plant organs including fruits, stems, leaves
and roots. Analyses of the chemical composition of
the fruits of S. sphenanthera have revealed consid-
erable differences in their composition in comparison
with the fruits of S. chinensis. The dibenzocyclooc-
tadiene lignans are the dominant group of secondary
metabolites in S. sphenanthera fruit extracts; they
have been found to contain compounds such as: pre-
gomisin, gomisins: C, S, K3, J and U, epigomisin O,
6-O-benzoylgomisin, benzoylgomisin U, methylgo-
misin, tigloylgomisin P, angeloylgomisin P,
schisantherins A–D, deoxyschisandrin, schisanthenol,
and isoschisandrin. Derivatives of dibenzocycloocta-
diene lignans have also been detected in the fruits, i.e.
C18-dibenzocyclooctadiene lignans—schisphenins
C–G (Fig. 1) and 6,7-seco-dibenzocyclooctadiene
lignan—schisphenone (Fig. 2) (Huang et al. 2011).
Moreover, other groups of lignans are also present in
the S. sphenanthera fruit (Zhu et al. 2007; Ren et al.
2010; Huang et al. 2011; Liu et al. 2012; Chen et al.
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2013). The confirmed ones include: 4-aryltetralin
lignans (schisandrone), aryltetralone lignans
(schisphentetralone A), 2,3-dimethyl-1,4-diarylbu-
tane lignans (D,L-anwulignan, (+)-anwulignan, and
sphenanlignan), and three 2,5-diaryltetrahydrofuran
lignans (chicanine, D-epigalbacine, and ganschisan-
drine) (Lu and Chen 2009; Huang et al. 2011).
Analyses of the composition of the stems of S.
sphenanthera have proved the existence, in addition
to those previously known, of: gomisins B, G and O,
epigomisin O, schisantherin A and D, marlignan E
and angeloylgomisin Q, and also new dibenzocy-
clooctadiene lignans—schisphenlignans A–D (Fig. 3)
(Liang et al. 2013). Moreover, the roots of S.
sphenanthera have been used to isolate and identify
butane-type lignans, besides the known ones, such as:
schiglaucins A and B, epoxyzuonin, talaumidin,
myristargenol A, and also eight previously unknown
tetrahydrofuran lignans (Jiang et al. 2015).
In addition to lignans, triterpenoids have been
isolated from S. sphenanthera fruits and identified as:
schizandronic acid (ganwuweizic acid), anwuweizic
acid, kadsuric acid, coccinic acid, schinalactones A–
C and G and schisanol (Lu and Chen 2009; Ren et al.
2009; He et al. 2010; Huang et al. 2011). Fruits of S.
sphenanthera are also a source of highly oxygenated
nortriterpenoids: sphenalactones A–D and sphenadi-
lactone C and sphenasin A (Fig. 4) (Xiao et al. 2007c;
Connolly and Hill 2010).
Schisandra henryi
In the available databases, very little information
could be found on detailed phytochemical analyses of
S. henryi. The research work has focused on analyz-
ing the chemical composition of the shoots and leaves
of S. henryi plants. Coexistence of as many as three
groups of lignans has been confirmed in S. henryi:
dibenzocyclooctadiene lignans, tetrahydrofuran lig-
nans and tetralin lignans (Liu et al. 1988; Li et al.
2004c; Iu et al. 2009; Christophe 2013). The diben-
zocyclooctadiene lignans occurring in S. henryi
include: schisantherin A and B, deoxyschisandrin,
schisandrin, gomisin G, benzoylgomisin Q and
isoanwulignan.
Studies on the chemical composition of the leaves
of male S. henryi specimens grown in Poland have
been confirmed by our own research. Analyses by the
LC-DAD and UHPLC—MS/MS methods confirmed
the presence of compounds from the three groups of
lignans: dibenzocyclooctadiene lignans (schisan-
therin E, schisandrin, gomisin G, angeloylgomisin
Q, benzoylgomisin Q, schisantherin A, schisantherin
B, gomisin F, deoxyschisandrin, schisandrin C,
angeloylgomisin O, and schisantherin D), aryltetralin
lignans (wulignan A1 and A2, epiwulignan A1,
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enshicine, and epienshicine) and tetrahydrofuran
lignans (henricine B) [unpublished].
The tetrahydrofuran lignans estimated only in S.
henryi stems are: ganschisandrin, wulignans A1 and
A2, epiwulignan A and epischisandron. Moreover, in
S. henryi, two lignans from this group have been
identified as unique to this species: henricine A and B
(Fig. 5) (Iu et al. 2009).
From the group of tetralin lignans, only one
compound has been identified in S. henryi shoots—
enshicine (Fig. 6) (Liu et al. 1984, 1988; Chen et al.
2003).
The second characteristic group of secondary
metabolites found in S. henryi are triterpenoids:
henrischinins A, B and C (identified only in leaves
and shoots), kadsuric acid, nigranoic acid, isoschisan-
drolic acid, and schisandrolic acid. In addition,
unique nortriterpenoid compounds have also been
identified in the shoots, such as: henridilactones: A,
B, C and D (Fig. 7) (Chen et al. 2003, 2010; Li et al.
2004c).
Schisandra rubriflora
From the available literature, it is known that
dibenzocyclooctadiene lignans occur in the S. rubri-
flora species (Li et al. 2004b, 2008; Mu et al. 2011).
Previous studies (from 1985) had indicated the
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occurrence of lignans characteristic of the Schisandra
genus, such as: schisandrin, schisandrin C,
deoxyschisandrin, schisanthenol, schisanthenol B,
schisantherin B, gomisin J and O, pregomisin and
meso-dihydroguaiaretic acid (Wang and Chen 1985).
Based on more recent studies, S. rubriflora fruit
extracts have been found to contain unique lignans (e.
g. rubrilignans) as well as other lignans, both those
known from the Schisandra genus such as gomisins
B, C, G, J, N, O, Q, S and T, isogomisin O, (+)-
gomisin K, schisandrin, schisandrin A, angeloylgo-
misin P and Q, benzoylgomisin Q, and those lesser-
known/rare ones such as wilsonilignan C, marlignans
G and L, epiwulignan A1, wulignan A2, (Xiao et al.
2010b; Mu et al. 2011). What is important and
noteworthy is that the fruit of S. rubriflora contains
derivatives of dibenzocyclooctadiene lignans that are
specific to this plant: rubrilignan A and B, and
rubschisantherin (Fig. 8) (Li et al. 2004a; Chen et al.
2006; Mu et al. 2011).
The stems of S. rubriflora were confirmed to
contain also other specific dibenzocyclooctadiene
lignans: rubrisandrin A and B (Fig. 8) and schiru-
brisins A–D (Fig. 9), together with the known ones:
schisandrin, schisantherin A, angeloylgomisin Q and
P, tigloylgomisin P, epigomisin O, interiotherin B,
gomisin D, benzoylgomisin Q, 6β-hydroxy-schisan-
drin A, 12-demethylwuweilignan I and machilin D
(Li et al. 2008).
Moreover, the leaves and stems have been confirmed
to contain the uncommon structures of dibenzocyclooc-
tadiene lignans such as: meso-dihydroguaiaretic acid,
meso-mono-methyl dihydroguaiaretic acid, 4,4′-(2R,3S)-
2,3-dimethylbutane-1,4-diyl)bis(1,2-dimethoxyben-
zene), tiegusanin L, (7S,8S,R-biar)-6,6,7,8-tetrahydro-
12,13-methylenedioxy-1,2,3,14-tetramethoxy-7,8-
dimethyldibenzo[a,c]cycloocten-9-one, and (8R,7′R,8R)-
5-hydroxy-4,3′,4′-trimethoxy-2,7′-cyclolignan (Xiao
et al. 2010b).
Also, our team has recently conducted research on
the exploration of the chemical composition of S.
rubriflora specimens grown in Poland. Preliminary
phytochemical analyses of leaf and fruit extracts
using the LC-DAD method showed the presence of
fourteen dibenzocyclooctadiene lignans. The total
amount of dibenzocyclooctadiene lignans in leaf
extracts was low (107 mg/100 g DW), but in fruit
extracts it was 6 times higher (653 mg/100 g DW).
The main compounds in fruit extracts were:
deoxyschisandrin, angeloyl/tigloyl-gomisin Q and
H, schisantherin A, benzoylgomisin P and γ-schisan-
drin [unpublished].
Recently, a lot of chemical studies on S. rubriflora
have concentrated on the nortriterpenoid group. New,
so far unknown, structures of nortriterpenoids have
been discovered in the leaves and stems of S.
rubriflora: rubriflorins A–J (Fig. 10), schirubridilac-
tones A–F, and other nortriterpenoids, including
lancifodilactones A, C, and D, micrandilactones A
and D, and henridilactones A–C (Xiao et al. 2007a, b,
Xiao et al. 2010b, c). Moreover, novel highly
unsaturated rearranged bisnortriterpenoids have been
detected in S. rubriflora stems: rubriflordilactones A
and B (Fig. 11) (Xiao et al. 2006a).
Li et al. (2005) reported the occurrence of specific
megastigmane glycosides (the megastigmane
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skeleton is characterized by a benzene ring substi-
tuted on carbons 1, 5 and 6, and an aliphatic chain of
four carbon atoms attached to carbon 6) in stem
extracts of S. rubriflora, namely (3S, 5R, 6S, 9R)-
megastigmane-3, 9-diol 3-O-[α-L-arabionfuranosyl-
(1→6)-β-D-glucopyranoside], 7-megastigmane-3-ol-
9-one 3-O-[α-L-arabionfuranosyl-(1→6)-β-D-glu-
copyranoside] (2), and megastigmane-3α, 4β, 9ξ-
triol 3-O-β-D-glucopyranoside.
Among the confirmed phenolic structures in stem
extracts were: one phenolic acid—glucosyringic acid,
and three flavonoids: naringin, didimin (acinoside,
isosakuranetin-7-O-rutinoside) and maesopsin-6-O-
glucopyranoside (Li et al. 2005).
The pharmacological potential
Schisandra sphenanthera
Schisandra sphenanthera is principally used as a
tonic and restorative in East-Asian countries to
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enhance the function of the liver and other organs
(Fan et al. 2014). The hepatoprotective effect is
associated with antiviral action and protection from
chemical hepatitis and various hepatotoxins (Zhu
et al. 2000; Xie et al. 2010). What has been proven is
that schisantherin A, B, C, and D, isolated from S.
sphenanthera fruits, show good effects in lowering
the glutamic-pyruvic transaminase level in the serum
of patients suffering from chronic viral hepatitis. In
addition to that, it was shown that schisantherin E and
deoxyschisandrin were not effective (Liu et al. 1978).
Recently, studies performed by the Chinese team
from Sun Yat-sen University in Guangzhou and
based on the herb-drug interaction demonstrated the
influence of S. sphenanthera fruit extracts on three
important drugs: cyclosporine A, paclitaxel and
tacrolimus.
The study on rats showed that cyclosporine A
blood concentration was significantly altered by co-
administration of ‘Wuzhi tablets’ (S. sphenanthera
fruit extract standardized on 7.5 mg of schisantherin
A per tablet) at a low dose of cyclosporine A
(1.89 mg/kg), but only slightly affected when an
ordinary dose of cyclosporine A (37.8 mg/kg) was
administrated. The low dose of cyclosporine A might
be more sensitive to associate application of CYP3A/
P-gp inhibitors or inducers (Xue et al. 2013).
With regard to co-administration of ‘Wuzhi
tablets’ with paclitaxel, the study on rats proved
significant increases of paclitaxel level in blood after
oral administration (AUC0–24h from 280.8 to
543.5 ng/mL). The pharmacokinetic data for in viral
paclitaxel administration with ‘Wuzhi tablets’
showed a relatively small but still significant increase
in AUC0–24h (from 163.6 to 212.7 ng/mL) and a
decrease in clearance (from 3.2 to 2.2 L/h/kg) (Jin
et al. 2011; Xue et al. 2013). Summing up, the S.
sphenanthera fruit extract significantly increased the
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concentration of paclitaxel in rat’s blood, and thus
increased the systemic exposure to this drug, which
should be taken into consideration in clinical use (Jin
et al. 2011).
The studies on co-administration of ‘Wuzhi
tablets’ with tacrolimus in rats indicated that most
of the tacrolimus tissue concentrations were slightly
increased after the accompanying dose of ‘Wuzhi
tablets’, but the whole blood concentration of
tacrolimus was greatly increased (threefold after a
concomitant ‘Wuzhi tablets’ dose) (Qin et al. 2010a).
Moreover, the influence of S. sphenanthera fruit
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extract on absorption and first-pass intestinal and
hepatic metabolism was confirmed. The mechanism
of action is based on the inhibited P-gp-mediated
efflux and CYP3A-mediated metabolism of tacroli-
mus, and the reduction in the intestinal first-pass
effect by the fruit extract was the major cause of the
increased tacrolimus oral bioavailability (Qin et al.
2010b).
In relation to the positive effect of S. sphenanthera
fruit extracts on hepatocytes, the protective effect of
Nan-wuweizi fruits on different drug-induced hepa-
totoxicity has also been studied. There has been
shown a protective effect toward acetaminophen. The
‘Wuzhi tablets’ (S. sphenanthera fruit extract stan-
dardized on 7.5 mg of schisantherin A per tablet)
prevented acetaminophen-induced liver injury by the
inhibition of P450-mediated acetaminophen meta-
bolic activation, activation of the NRF2-ARE
pathway to induce detoxification and antioxidation,
and regulation of p53/p21-mediated cell cycle to
facilitate liver regeneration after acetaminophen-
induced liver injury (Bi et al. 2013; Fan et al. 2014).
Nan-wuweizi extract also has antioxidant proper-
ties and might be useful in the prevention and
treatment of hyperproliferative and inflammatory skin
diseases (Huyke et al. 2007; Lu and Chen 2009). This
mechanism of action is currently protected by patents
(Garnier et al. 2012; Garnier and Msika 2013). Huyke
et al. (Huyke et al. 2007) showed that the studied
non-polar S. sphenanthera fruit extract obtained by
CO2 extraction was the most active with a half-
maximal inhibitory concentration of 20 µg/mL. In a
cell-free enzyme inhibition assay with recombinant
cyclooxygenase-2 (COX-2), this extract showed
dose-dependent inhibitition of COX-2 catalysed
prostaglandin PGE2 production (IC50=0.2 µg/mL).
It also reduced the ultraviolet-B (UVB)-induced
PGE2 production (IC50=4 µg/mL) and COX-2
expression in HaCaT keratinocytes.
Schisandra henryi
Scientific papers describing the biological activity of
S. henryi focus on the cytotoxic activity of this raw
material (Christophe 2013).
Chen et al. (2005) tested some biological activity
of compounds isolated from S. henryi stems. They
proved the significant cytotoxic effect of gomisin G
on leukemia and Hela cells in vitro with IC50 of
5.51 µg/mL toward leukemia and Hela cells. Schisan-
therin A and benzoylgomisin Q showed moderate
cytotoxic activities on leukemia cells, with IC50 of
55.1 and 61.2 µg/mL, respectively. Moreover, ben-
zoylgomisin Q also showed cytotoxicity on Hela
cells, with IC50 of 61.2 µg/mL.
The studies performed on the lanostane triter-
penoids isolated from S. henryi stems: schiprolactone
A and B, and schisandronic acid, have proven them to
show moderate cytotoxic activity against leukemia
cells in vitro, with IC50 equal: 0.0097, 0.01 and
0.0099 µmol/mL, respectively and against Hela cells
in vitro with IC50 equal: 0.097, 0.1 and 0.099 µmol/
mL, respectively (Chen et al. 2003).
Moreover, henrischinins A and B—isolated from
S. henryi leaves and stems, showed weak cytotoxicity
against HL-60 cell lines with IC50 values of 16.5 and
10.5 μM, respectively (Xue et al. 2011).
Schisandra rubriflora
Schisandra rubriflora has long been used as a tonic
remedy in Chinese folk medicine (Wu et al. 2008).
As far as biological activities of S. rubriflora fruit
extracts are concerned, until now only anti-HIV-1
property was shown by Chinese teams (Chen et al.
2006; Mu et al. 2011). For the isolated rubrilignans A
and B, a weak anti-HIV-1 activity was shown, with
EC50 values of 2.26 and 1.82 mg/mL, respectively
(Mu et al. 2011). The inhibitory effects against HIV
replication in H9 lymphocytes in vitro was proven for
rubrisandrins A, schisanhenol, gomisin J, M1 and M2
isolated form S. rubriflora fruit, too. The results
showed that gomisin M1 was the most potent
compound, with an EC50 of less than 0.65 µM (Chen
et al. 2006). In connection with these studies, the first
concise synthesis of 6,5,5,5-tetracyclic moiety
(DEFG ring system) in rubriflordilactone B, related
to promising anti-HIV activity, has recently been
achieved (Peng et al. 2015).
Additionally, it has been indicated that S. rubri-
flora stem extracts are effective in reducing the level
of glutamic-pyruvic transaminase, which may be of
use in the treatment and diagnosis of liver and bile
duct diseases (Li et al. 2004a).
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The potential in biotechnological studies
Plant in vitro cultures, and the possibility of increas-
ing the production of secondary metabolites offered
by various techniques used in plant biotechnology,
create opportunities for applying them in the phar-
maceutical, cosmetics and food industries. Specific
strategies used to increase the production of active
compounds take advantage of such treatments as:
selection of highly-productive cell lines, optimization
of culture conditions (selection of culture medium,
composition of plant growth regulators), type of
culture (agar, agitated), degree of organogenesis
(shoot, callus), illumination and temperature condi-
tions, application of elicitors, or genetic
transformation. In addition, the ability to provide
industry with valuable raw materials and their
production on a larger scale create opportunities
based on the development of protocols for micro-
propagation of selected species. Cultivation of
in vitro cultures makes it possible to control and
stimulate the production of secondary metabolites.
The developed micropropagation protocols ensure the
obtaining of highly productive copies of medicinal
plant species valuable for the pharmaceutical, cos-
metics and food industries (Verpoorte et al. 2002;
Walsh 2002, 2003; Ma et al. 2005; Schneider et al.
2013; Georgiev et al. 2014).
In vitro cultures of the species S. chinensis are the
object of interest of select research centres in the
world: Japanese, Czech, and Polish. To date, micro-
propagation protocols for this species have been
developed (Březinová et al. 2010; Kohda et al. 2012;
Szopa et al. 2016b, 2017b, 2018). Studies on the
endogenous accumulation of secondary metabolites
in S. chinensis in vitro cultures are of increasing
popularity. Considerable achievements in this direc-
tion can be credited to our research team. Our studies
are mainly focused on the production of dibenzocy-
clooctadiene lignans and phenolic acids. S. chinensis
shoot cultures cultivated by us have been used to
conduct tests on the optimization of culture param-
eters—selection of culture type, composition of
culture medium, culture system and illumination
conditions. In addition, the process of growing
cultures in various types of bioreactors has been
optimized (Szopa and Ekiert 2012, 2016, Szopa et al.
2016b, 2017b, 2018). The concentrations of lignans
obtained in the in vitro grown biomass are consid-
erable, based on ESI–MS/MS and LC-DAD assays,
similar to the amounts of these compounds in the
material grown in vivo. Generally, the amount of the
main S. chinensis lignan—schisandrin (66 mg/100 g
DW), was 2.2 times higher in biomass extracts than
in extracts from the leaves (30 mg/100 g DW) of the
parent plant, but 2 times lower than in the fruits
(132 mg/100 g DW). Also, the maximum amounts of
the other main lignans: gomisin A and deoxyschisan-
drin, were comparable with their amounts in the
leaves, but 3.18 and 1.39 times lower than in the
fruits, respectively (Szopa et al. 2016b).
In the light of the results obtained by our group
with in vitro cultures of S. chinensis, other species of
the Schisandra genus characterized as part of this
S. sphenanthera S. henryi S. rubriflora
Fig. 12 The microshoot in vitro cultures of three Schisandra species: S. sphenanthera, S. henryi and S. rubriflora-agar Murashige and
Skoog medium with 1 mg/L BA (6-benzyladenie) and 1 mg/L NAA (1-naphthaleneacetic acid) after 3-weeks of growth
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review are extremely interesting objects for further
study. Our team has successfully initiated in vitro
cultures of S. sphenanthera, S. henryi and S. rubri-
flora (Fig. 12) [unpublished]. The optimal culture
medium for all three species proved to be the medium
according to Murashige and Skoog (1962) with
different combinations of plant growth regulators
(from the group of cytokinins: 6-benzyladenine,
thidiazuron, zeatin; and auxins: 1-naphthaleneacetic
acid, indole-3-acetic acid and indole-3-butyric acid).
Preliminary chromatographic analyses confirmed the
presence of dibenzocyclooctadiene lignans in the
in vitro cultured biomass of these species. In the near
future, we plan intensive biotechnological studies for
these three Schisandra species. Within the project
framework, we aim to optimize the cultivation of
in vitro cultures. The optimization involves aspects
such as: choice of culture media, composition of plant
growth regulators, duration of cultivation, and type of
in vitro cultures. The major focus of this optimization
is to obtain high amounts of secondary metabolites in
the biomass (as well as in the growth media) of
in vitro cultures. The planned biotechnological stud-
ies on new established Schisandra genus in vitro
cultures are completely innovative. Based on the
examination of the available literature and databases,
research in this field of plant biotechnology of the
Schisandra genus has not been conducted yet.
Conclusions
In the light of the presented overview of scientific
data on the three species of the genus Schisandra: S.
sphenanthera, S. henryi and S. rubriflora species have
an extremely valuable potential for use not only in
medicine but also in cosmetology and the food
industry. They undoubtedly represent an attractive
alternative to the known species S. chinensis which is
firmly rooted in Eastern medicine. Intensive research
into the chemical composition of these species has
discovered new and unique compounds besides the
known S. chinensis lignans and triterpenoids. Their
biological effects, although often studied, still remain
to be explored. There can be no doubt that these
species are a potential source of many biologically
active, valuable secondary metabolites. They should
become the goal of further scientific work on these
species.
In vitro cultures and finding alternative biotech-
nological solutions for obtaining biomass from S.
sphenanthera, S. henryi and S. rubriflora seem to be a
particularly valuable direction of research, which is
extremely important due to the limited area of their
natural occurrence and the alternative need to secure
the acquisition of raw materials.
These species showed an interesting chemical
composition as well as obvious biological activity
and will have expanding phytotherapeutic applica-
tions in Europe. The proposed biotechnological
solutions can be an alternative to importing raw
materials from China.
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